Prostatype Genomics AB Logo

Prostatype Genomics AB

Provides a genetic test to assess prostate cancer aggressiveness and guide treatment choices.

PROGEN | ST

Overview

Corporate Details

ISIN(s):
SE0022574554 (+2 more)
LEI:
549300JO6MPCGPVHVU91
Country:
Sweden
Address:
Gustav III:s Boulevard 34, 169 73 Solna
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Prostatype Genomics AB specializes in the development, manufacturing, and marketing of the prognostic genetic test, Prostatype®. The test is designed to provide a comprehensive assessment of the aggressiveness of diagnosed prostate cancer, particularly for patients with localized disease. It serves as a decision-making tool for clinicians and patients to help determine appropriate treatment strategies. The Prostatype® system uses existing biopsy tissue to analyze the expression of three key genes. This genetic data is combined with standard clinical parameters (PSA, Gleason Score, Tumor Stage) to calculate a proprietary P-score, which quantifies the risk of cancer mortality. By offering a more precise prognosis, the test aims to minimize both over- and under-treatment, thereby improving patient quality of life and saving healthcare resources.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Prostatype Genomics AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Prostatype Genomics AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AuBEX CORPORATION Logo
High-precision manufacturer of nibs for stationery, cosmetics, and medical infusion technology.
Japan 3583
Audientes A/S Logo
Develops smart, self-fitting, and affordable hearing aids for adults with hearing loss.
Denmark AUDNTS
Bactiguard Holding Logo
Licenses a patented coating to MedTech partners to prevent medical device infections.
Sweden BACTI
BBS-Bioactive Bone Substitutes Oyj Logo
Developed a bioactive bone graft substitute for orthopedic surgery before filing for bankruptcy.
Finland BONE
BELLUSCURA PLC Logo
Develops portable oxygen concentrators for patients needing supplemental oxygen.
United Kingdom BELL
BENO TNR, Inc. Logo
A diversified firm in biotech, wearable robotics, and eco-friendly building materials.
South Korea 206400
BibbInstruments AB Logo
Develops electric endoscopic biopsy tools for accurate cancer diagnosis in GI, lung, and urology.
Sweden BIBB
BIOBIJOU Co., Ltd. Logo
Develops and manufactures injectable aesthetic solutions like HA fillers for global markets.
South Korea 489460
Biocartis Group NV Logo
Develops an automated PCR platform for fast molecular diagnostics in oncology & infectious diseases.
Belgium BCART
Biocorp Logo
Develops and manufactures connected drug delivery systems and medical devices for pharma.
France ALCOR

Talk to a Data Expert

Have a question? We'll get back to you promptly.